Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Corvus Pharmaceuticals Inc.
CRVS
$
3.58
-11%
Tue February 2nd, 2021
17:11
Analysis
Marketplace Contributors 2021 Top Ideas - Part 2
Seeking Alpha
Wed January 20th, 2021
14:59
Analysis
Corvus Pharmaceuticals: Undervalued Based On COVID-19 Opportunity And Oncology Assets
Seeking Alpha
Sun October 11th, 2020
19:32
Analysis
Digest
Week In Review: $1.5 Billion Total In Week's China Deals
Seeking Alpha
Mon October 5th, 2020
13:31
Press Releases
Analysis
Thinking about buying stock in Enlivex Therapeutics, Corvus Pharmaceuticals, Livent Corp, Solid Biosciences, or Boxlight Corp?
PR Newswire
Tue July 21st, 2020
17:31
IPO
Analysis
IPO Update: iTeos Therapeutics Finalizes IPO Plan
Seeking Alpha
Thu July 9th, 2020
12:43
Analysis
Corvus Pharmaceuticals (CRVS) Catches Eye: Stock Jumps 8.4%
Zacks
Wed July 8th, 2020
13:58
Analysis
Corvus Starts Immunotherapy Study on Coronavirus, Stock Rises
Zacks
11:34
Analysis
Corvus Pharmaceuticals stock price target raised to $8 from $5 at Wedbush
MarketWatch
+ 2 more
Tue July 7th, 2020
14:45
Press Releases
Analysis
Thinking about buying stock in Annovis Bio, Corvus Pharmaceuticals, MGM Resorts, PDS Biotechnology, or Remark Holdings?
PR Newswire
13:36
Corvus Skyrockets After Initiating COVID-19 Clinical Trial
Benzinga
+ 1 more
Thu July 2nd, 2020
19:59
IPO
Analysis
iTeos Therapeutics Begins U.S. IPO Rollout
Seeking Alpha
Wed May 20th, 2020
16:00
Analysis
What Makes Corvus (CRVS) a New Buy Stock
Zacks
